Epstein Secrets

our amended and restated voting agreement, our directors were elected as follows: Messrs. Dorsey, McKelvey. Khosla, and Johnson and Drs. Summers and Simmons were elected as the designees nominated by holders of our common stock; Mr. Botha was elected as the designee nominated by holders of our Series B

srs. Dorsey, McKelvey. Khosla, and Johnson and Drs. Summers and Simmons were elected as the designees nominated by holders of our common stock; Mr. Botha was elected as the designee nominated by holders of our Series B convertible preferred stock; • Ms. Meeker was elected as the designee nominated by

Exchange. Nominating and Corporate Governance Committee Our nominating and governance committee is comprised of Messrs. Johnson and Viniar and Dr. Simmons, each of whom satisfies the requirements for independence under the applicable rules and regulations of the SEC and listing standards of the New Yo

S-1/A Table of Contents Compensation Committee Our compensation committee is comprised of Ms. Meeker and Mr. Botha, each of whom satisfies the requirements for independence under the applicable rules and regulations of the SEC and listing standards of the New Yor

ting schedule as the option. All of the shares vest on January 1, 2016, subject to Mr. Johnson's continued service with us. On August 11, 2015, Dr. Simmons was granted an option to purchase 38,000 shares of our common stock. This option is early exercisable. All of the shares subject to the option vest

S- I/A serving on our board of directors or compensation committee. Ms. Meeker, a General Partner of Kleiner Perkins Caufield & Byers, and Mr. Botha. a Managing Member of Sequoia Capital, comprise our compensation committee. Entities affiliated with Kleiner Perkins Caufield & Byers and entities a